Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.76B |
| 2 |
Tesla
TSLA
|
+$1.37B |
| 3 |
Amazon
AMZN
|
+$623M |
| 4 |
AbbVie
ABBV
|
+$398M |
| 5 |
Qualcomm
QCOM
|
+$394M |
Top Sells
| 1 |
CELG
Celgene Corp
CELG
|
+$1.54B |
| 2 |
Johnson & Johnson
JNJ
|
+$603M |
| 3 |
Micron Technology
MU
|
+$366M |
| 4 |
Meta Platforms (Facebook)
META
|
+$365M |
| 5 |
UnitedHealth
UNH
|
+$353M |
Sector Composition
| 1 | Healthcare | 21.21% |
| 2 | Technology | 12.91% |
| 3 | Consumer Discretionary | 10.45% |
| 4 | Financials | 8.47% |
| 5 | Industrials | 7.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
INWK
2576
DELISTED
InnerWorkings, Inc.
INWK
| $1.12M | ﹤0.01% |
203,600
+84,900
| +72% | +$468K |
|
2577
Vanguard Mid-Cap Value ETF
VOE
$19B
| $1.12M | ﹤0.01% |
9,400
+4,800
| +104% | +$572K |
|
|
SPRT
2578
DELISTED
support.com, Inc.
SPRT
| $1.12M | ﹤0.01% |
1,026,536
| – | – |
|
|
ADMS
2579
DELISTED
Adamas Pharmaceuticals, Inc.
ADMS
| $1.11M | ﹤0.01% |
292,780
+169,145
| +137% | +$641K |
|
2580
iShares MSCI Australia ETF
EWA
$1.56B
| $1.11M | ﹤0.01% |
49,000
+19,400
| +66% | +$439K |
|
2581
Vanguard Large-Cap ETF
VV
$45.3B
| $1.11M | ﹤0.01% |
+7,500
| New | +$1.11M |
|
|
SGMA
2582
DELISTED
Sigmatron International
SGMA
| $1.1M | ﹤0.01% |
272,928
+5,538
| +2% | +$22.3K |
|
2583
Innodata
INOD
$1.94B
| $1.1M | ﹤0.01% |
963,153
+20,600
| +2% | +$23.5K |
|
2584
SPDR Bloomberg Emerging Markets Local Bond ETF
EBND
$2.09B
| $1.1M | ﹤0.01% |
39,227
+29,368
| +298% | +$820K |
|
2585
BioXcel Therapeutics
BTAI
$54.1M
| $1.09M | ﹤0.01% |
4,681
-175
| -4% | -$40.9K |
|
2586
Prothena Corp
PRTA
$454M
| $1.09M | ﹤0.01% |
69,100
+24,100
| +54% | +$382K |
|
|
SOL
2587
Emeren Group
SOL
$95.5M
| $1.09M | ﹤0.01% |
772,442
-6,409
| -0.8% | -$9.07K |
|
2588
iShares Core Moderate Allocation ETF
AOM
$1.61B
| $1.09M | ﹤0.01% |
27,163
+16,063
| +145% | +$645K |
|
2589
Schwab US Aggregate Bond ETF
SCHZ
$9.02B
| $1.08M | ﹤0.01% |
40,356
+16,756
| +71% | +$448K |
|
2590
Pluri
PLUR
$40.5M
| $1.08M | ﹤0.01% |
34,177
+10,898
| +47% | +$343K |
|
2591
Tenet Healthcare
THC
$17.1B
| $1.08M | ﹤0.01% |
28,275
-16,800
| -37% | -$639K |
|
2592
Vanguard Long-Term Corporate Bond ETF
VCLT
$6.96B
| $1.07M | ﹤0.01% |
10,600
+1,600
| +18% | +$162K |
|
2593
Pure Cycle
PCYO
$271M
| $1.07M | ﹤0.01% |
85,200
-9,792
| -10% | -$123K |
|
|
PSB
2594
DELISTED
PS Business Parks, Inc.
PSB
| $1.07M | ﹤0.01% |
6,500
+1,088
| +20% | +$179K |
|
2595
Cannae Holdings
CNNE
$1.13B
| $1.07M | ﹤0.01% |
28,801
-145,999
| -84% | -$5.43M |
|
2596
Security National Financial
SNFCA
$236M
| $1.07M | ﹤0.01% |
251,201
+23,498
| +10% | +$100K |
|
|
ALLK
2597
DELISTED
Allakos
ALLK
| $1.07M | ﹤0.01% |
11,200
-151,500
| -93% | -$14.4M |
|
2598
Ryerson Holding
RYI
$727M
| $1.07M | ﹤0.01% |
+90,200
| New | +$1.07M |
|
|
RBCN
2599
DELISTED
Rubicon Technology, Inc.
RBCN
| $1.07M | ﹤0.01% |
128,104
+2,900
| +2% | +$24.1K |
|
2600
Linde
LIN
$227B
| $1.07M | ﹤0.01% |
5,000
-173,800
| -97% | -$37M |
|